2023.07.18 - No.8 Children & Entry Clearance

Children & Entry Clearance Webinar: Sole Responsibility, Serious & Compelling & Article 8

Content

In this free webinar held on 18 July 2023, Adam Pipe of No.8 Chambers looks at the issues arising in making an entry clearance application in order to bring a child to the United Kingdom. Adam looks at:

  • Rule 297 & the Appendix FM child route
  • The Sole Responsibility Requirement
  • Demonstrating serious and compelling family or other considerations which make exclusion of the child undesirable
  • Arguing Article 8 in child entry clearance cases
  • GEN.3.2 & GEN.3.3 of Appendix FM
  • The relevance of section 55 and best interests in child entry clearance cases

Adam will look at the relevant rules, case law and policy and will give practical guidance on making successful applications and arguing appeals before the Tribunal.

This webinar is a must for all those involved in making entry clearance applications for children.

Target Audience

This webinar is aimed at legal practitioners and those working with them, with an assumed basic knowledge of the topic area.

Resources

The recording and slides were available for three months following the event.

Donations

Our webinars are provided free of charge, however, if you have enjoyed any of our webinars, please do consider donating to one of our chosen charities below:

Great Ormond Street Hospital Children’s Charity

LOROS, the Leicestershire and Rutland Hospice

Support Through Court

Reviews

If you have enjoyed this webinar, please do consider leaving us a Google, Facebook or Trustpilot review using the relevant button below.  We would be very grateful to receive a review and it will encourage us to provide further free webinars.

Speakers

Adam Pipe | Barrister | No.8 Chambers

Adam Pipe is a barrister specialising in Immigration, Asylum and Human Rights Law and is ranked by Chambers and Partners for Immigration Law in the Midlands. Adam provides regular updates on the law at training events and on social media.